BACKGROUND: Chemotherapy treatment for pediatric acute lymphoblastic leukemia (ALL) has been associated with long-term cognitive impairments in some patients. However, the neurobiologic mechanisms underlying these impairments, particularly in young survivors, are not well understood. This study aimed to examine intrinsic functional brain connectivity in pediatric ALL and its relationship with cognitive status. PROCEDURE: We obtained resting state functional magnetic resonance imaging (rsfMRI) and cognitive testing data from 15 ALL survivors age 8-15 years and 14 matched healthy children. The ALL group had a history of intrathecal chemotherapy treatment but were off-therapy for at least 6 months at the time of enrollment. We used seed-based analyses to compare intrinsic functional brain network connectivity between the groups. We also explored correlations between connectivity and cognitive performance, demographic, medical, and treatment variables. RESULTS: We demonstrated significantly reduced connectivity between bilateral hippocampus, left inferior occipital, left lingual gyrus, bilateral calcarine sulcus, and right amygdala in the ALL group compared to controls. The ALL group also showed regions of functional hyperconnectivity including right lingual gyrus, precuneus, bilateral superior occipital lobe, and right inferior occipital lobe. Functional hypoconnectivity was associated with reduced cognitive function as well as younger age at diagnosis in the ALL group. CONCLUSIONS: This is the first study to demonstrate that intrinsic functional brain connectivity is disrupted in pediatric ALL following chemotherapy treatment. These results help explain cognitive dysfunction even when objective test performance is seemingly normal. Children diagnosed at a younger age may show increased vulnerability to altered functional brain connectivity.
BACKGROUND: Chemotherapy treatment for pediatric acute lymphoblastic leukemia (ALL) has been associated with long-term cognitive impairments in some patients. However, the neurobiologic mechanisms underlying these impairments, particularly in young survivors, are not well understood. This study aimed to examine intrinsic functional brain connectivity in pediatric ALL and its relationship with cognitive status. PROCEDURE: We obtained resting state functional magnetic resonance imaging (rsfMRI) and cognitive testing data from 15 ALL survivors age 8-15 years and 14 matched healthy children. The ALL group had a history of intrathecal chemotherapy treatment but were off-therapy for at least 6 months at the time of enrollment. We used seed-based analyses to compare intrinsic functional brain network connectivity between the groups. We also explored correlations between connectivity and cognitive performance, demographic, medical, and treatment variables. RESULTS: We demonstrated significantly reduced connectivity between bilateral hippocampus, left inferior occipital, left lingual gyrus, bilateral calcarine sulcus, and right amygdala in the ALL group compared to controls. The ALL group also showed regions of functional hyperconnectivity including right lingual gyrus, precuneus, bilateral superior occipital lobe, and right inferior occipital lobe. Functional hypoconnectivity was associated with reduced cognitive function as well as younger age at diagnosis in the ALL group. CONCLUSIONS: This is the first study to demonstrate that intrinsic functional brain connectivity is disrupted in pediatric ALL following chemotherapy treatment. These results help explain cognitive dysfunction even when objective test performance is seemingly normal. Children diagnosed at a younger age may show increased vulnerability to altered functional brain connectivity.
Authors: Kevin R Krull; Deepa Bhojwani; Heather M Conklin; Deqing Pei; Cheng Cheng; Wilburn E Reddick; John T Sandlund; Ching-Hon Pui Journal: J Clin Oncol Date: 2013-05-06 Impact factor: 44.544
Authors: Gregory T Armstrong; Wilburn E Reddick; Ronald C Petersen; Aimee Santucci; Nan Zhang; Deokumar Srivastava; Robert J Ogg; Claudia M Hillenbrand; Noah Sabin; Matthew J Krasin; Larry Kun; Ching-Hon Pui; Melissa M Hudson; Leslie L Robison; Kevin R Krull Journal: J Natl Cancer Inst Date: 2013-04-12 Impact factor: 13.506
Authors: Riejanne Seigers; Jessica Timmermans; Hans J van der Horn; Erik F J de Vries; Rudi A Dierckx; Lydia Visser; Sanne B Schagen; Frits S A M van Dam; Jaap M Koolhaas; Bauke Buwalda Journal: Behav Brain Res Date: 2009-10-17 Impact factor: 3.332
Authors: Ericka L Wodka; Christopher Loftis; Stewart H Mostofsky; Cristine Prahme; Jennifer C Gidley Larson; Martha B Denckla; E Mark Mahone Journal: Arch Clin Neuropsychol Date: 2008-02-19 Impact factor: 2.813
Authors: Kevin R Krull; Kristina K Hardy; Lisa S Kahalley; Ilse Schuitema; Shelli R Kesler Journal: J Clin Oncol Date: 2018-06-06 Impact factor: 44.544
Authors: Aneesh Hehr; Allesandra S Iadipaolo; Austin Morales; Cindy Cohen; Jeffrey W Taub; Felicity W K Harper; Elimelech Goldberg; Martin H Bluth; Christine A Rabinak; Hilary A Marusak Journal: Pediatr Blood Cancer Date: 2022-08-04 Impact factor: 3.838
Authors: Hilary A Marusak; Allesandra S Iadipaolo; Shelley Paulisin; Felicity W Harper; Jeffrey W Taub; Kristopher Dulay; Farrah Elrahal; Craig Peters; Kelsey Sala-Hamrick; Laura M Crespo; Christine A Rabinak Journal: Pediatr Blood Cancer Date: 2018-09-30 Impact factor: 3.167
Authors: Shelli R Kesler; Robert Ogg; Wilburn E Reddick; Nicholas Phillips; Matthew Scoggins; John O Glass; Yin Ting Cheung; Ching-Hon Pui; Leslie L Robison; Melissa M Hudson; Kevin R Krull Journal: Brain Connect Date: 2018-08